Tag: candidates

LEXINGTON, Mass. and AMSTERDAM, June 25, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously announced underwritten public offering of 5,686,813 ordinary shares at a public offering price of $45.50 per share, which includes 741,758 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the offering. The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, were approximately $259 million. All securities in the offering were sold by uniQure.

Hannover, Germany, June 25, 2026 (GLOBE NEWSWIRE) -- EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis
—Long-Term, Open-Label Study to Enroll Approximately 3,000 Patients Across Europe—

Optimized capital structure, retiring short-term maturing debt

— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control —

TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce today that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top”), has entered into a binding memorandum of understanding (the “MOU”) setting out the principal commercial terms for a proposed definitive distribution agreement (the “Definitive Agreement”) with ExoLyra LLC, which operates as an arm’s length third party (“ExoLyra”).

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- The Kevin Kuykendall Grant for Student Athletes officially opens its application cycle, offering a dedicated financial award to undergraduate students nationwide who balance academic pursuits with athletic ambitions. Founded by seasoned entrepreneur and former professional baseball player Kevin D. Kuykendall, this initiative supports the next generation of sports industry leaders, including competitive athletes, future coaches, and aspiring sports management professionals.

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- The Stuart Piltch Scholarship for Entrepreneurs officially opens its latest application cycle for the 2026 academic year, continuing its established tradition of supporting undergraduate students who demonstrate an exceptional passion for innovation and business leadership. This annual initiative aims to identify and cultivate forward-thinking individuals who possess a strong entrepreneurial mindset and a commitment to driving positive change across various industry sectors.

MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces an educational webinar exploring the unmet needs in neurologic oncology (specifically glioma and glioblastoma) and how theranostics may help address these.

Sanofi appoints Paulo Fontoura as Global Head of R&D